Invesco’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,877
| Closed | -$48.3K | – | 3769 |
|
|
2024
Q3 | $48.3K | Buy |
3,877
+1,176
| +44% | +$14.6K | ﹤0.01% | 3675 |
|
|
2024
Q2 | $35.1K | Buy |
2,701
+836
| +45% | +$10.9K | ﹤0.01% | 3837 |
|
|
2024
Q1 | $42.2K | Sell |
1,865
-33
| -2% | -$747 | ﹤0.01% | 3800 |
|
|
2023
Q4 | $24.6K | Sell |
1,898
-2,356
| -55% | -$30.6K | ﹤0.01% | 3784 |
|
|
2023
Q3 | $85.5K | Buy |
4,254
+618
| +17% | +$12.4K | ﹤0.01% | 3726 |
|
|
2023
Q2 | $97.6K | Buy |
3,636
+754
| +26% | +$20.2K | ﹤0.01% | 3715 |
|
|
2023
Q1 | $168K | Buy |
2,882
+474
| +20% | +$27.7K | ﹤0.01% | 3630 |
|
|
2022
Q4 | $123K | Buy |
2,408
+81
| +3% | +$4.13K | ﹤0.01% | 3772 |
|
|
2022
Q3 | $191K | Buy |
2,327
+254
| +12% | +$20.8K | ﹤0.01% | 3671 |
|
|
2022
Q2 | $141K | Sell |
2,073
-30
| -1% | -$2.04K | ﹤0.01% | 3791 |
|
|
2022
Q1 | $232K | Sell |
2,103
-2
| -0.1% | -$221 | ﹤0.01% | 3700 |
|
|
2021
Q4 | $203K | Sell |
2,105
-172
| -8% | -$16.6K | ﹤0.01% | 3732 |
|
|
2021
Q3 | $199K | Buy |
2,277
+370
| +19% | +$32.3K | ﹤0.01% | 3774 |
|
|
2021
Q2 | $295K | Buy |
1,907
+695
| +57% | +$108K | ﹤0.01% | 3609 |
|
|
2021
Q1 | $191K | Sell |
1,212
-443
| -27% | -$69.8K | ﹤0.01% | 3664 |
|
|
2020
Q4 | $385K | Buy |
1,655
+676
| +69% | +$157K | ﹤0.01% | 3288 |
|
|
2020
Q3 | $215K | Sell |
979
-10
| -1% | -$2.2K | ﹤0.01% | 3406 |
|
|
2020
Q2 | $281K | Sell |
989
-4,614
| -82% | -$1.31M | ﹤0.01% | 3328 |
|
|
2020
Q1 | $1.61M | Sell |
5,603
-10,038
| -64% | -$2.89M | ﹤0.01% | 2500 |
|
|
2019
Q4 | $4.5M | Sell |
15,641
-2,983
| -16% | -$858K | ﹤0.01% | 2223 |
|
|
2019
Q3 | $2.69M | Buy |
+18,624
| New | +$2.69M | ﹤0.01% | 2470 |
|
|
2015
Q3 | – | Sell |
-13
| Closed | -$5K | – | 3864 |
|
|
2015
Q2 | $5K | Buy |
+13
| New | +$5K | ﹤0.01% | 4203 |
|